B. Metzler seel. Sohn & Co’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.59M Buy
9,551
+1,379
+17% +$706K 0.04% 234
2025
Q4
$4.59M Sell
8,172
-1,128
-12% -$640K 0.04% 234
2025
Q3
$4.78M Sell
9,300
-130
-1% -$56.8K 0.04% 214
2025
Q2
$2.96M Buy
9,430
+1,799
+24% +$540K 0.03% 301
2025
Q1
$2.33M Sell
7,631
-1,211
-14% -$407K 0.02% 324
2024
Q4
$2.94M Sell
8,842
-438
-5% -$149K 0.03% 274
2024
Q3
$3.1M Buy
9,280
+147
+2% +$55.8K 0.03% 292
2024
Q2
$3.76M Sell
9,133
-173
-2% -$68.5K 0.04% 235
2024
Q1
$3.76M Sell
9,306
-1,395
-13% -$490K 0.04% 242
2023
Q4
$3.28M Buy
10,701
+368
+4% +$99.3K 0.04% 254
2023
Q3
$2.5M Sell
10,333
-18,039
-64% -$4.61M 0.04% 272
2023
Q2
$6.81M Buy
28,372
+12,512
+79% +$2.6M 0.09% 153
2023
Q1
$2.98M Buy
15,860
+478
+3% +$98.9K 0.05% 217
2022
Q4
$3.27M Buy
15,382
+606
+4% +$121K 0.06% 209
2022
Q3
$2.32M Buy
14,776
+152
+1% +$24.3K 0.04% 252
2022
Q2
$2.19M Sell
14,624
-1,636
-10% -$237K 0.04% 274
2022
Q1
$2.66M Buy
16,260
+5,356
+49% +$883K 0.04% 281
2021
Q4
$2.39M Sell
10,904
-2,409
-18% -$504K 0.03% 295
2021
Q3
$2.52M Hold
13,313
0.04% 267
2021
Q2
$2.35M Sell
13,313
-1,391
-9% -$240K 0.04% 271
2021
Q1
$2.41M Sell
14,704
-2,310
-14% -$353K 0.04% 263
2020
Q4
$2.35M Buy
+17,014
New +$2.14M 0.04% 237

Other funds holding MEDP

B. Metzler seel. Sohn & Co's MEDP Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co increased its Medpace (MEDP) stake by 17% in Q1 2026, buying an estimated $706K and bringing the position to 9,551 shares worth $4.59M. The position accounts for 0.04% of the portfolio, ranked #234.

B. Metzler seel. Sohn & Co first reported a position in MEDP in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.81M in Q2 2023. 731 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 9,551 shares of Medpace worth $4.59M as of Q1 2026.
  • B. Metzler seel. Sohn & Co bought 1,379 Medpace shares in Q1 2026, an estimated $706K.
  • Medpace made up 0.04% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #234 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Medpace in Q4 2020 and has held it in 22 quarters since.
  • B. Metzler seel. Sohn & Co's Medpace position peaked at $6.81M in Q2 2023.
  • 731 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.